
From Tissue to Mechanism to Decision: Building AI for Computational Oncology
Episode 72
In this episode of Data in Biotech, host Ross Katz sits down with Arvind Rao, Professor of Computational Medicine and Bioinformatics at the University of Michigan, for a discussion on the gap between what biomedical AI can do and what it can reliably be trusted to do in clinical practice. Arvind's research sits at the intersection of computational oncology and AI governance and his lab works across H&E histopathology, multiplex immunofluorescence, spatial transcriptomics, and single-cell RNA sequencing, not just to build predictive models, but to understand the full lifecycle from data to model to inference, and to ask where that lifecycle can be trusted and where it can't. The conversation moves through two of his recent papers on SPIFEE, a graph-based framework that replaces scalar interaction scores in the tumor microenvironment with spatially resolved functional representations, and a multimodal framework that traces a path from stained tissue slides to nominated drug targets via morphological pattern discovery and spatial transcriptomic mapping.
Publisher
Data in Biotech
Link
www.corrdyn.com/
Published
June 2, 2026
Duration
47 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
CorrDyn
Data in Biotech
@datainbiotech
#mechanism #buildingai #computationaloncology #lifesciences
